Authors

Editor, Communications Division, American Academy of Ophthalmology San Francisco

Svein Erik Thomassen

Svetlana Anisimova, MD, PhD

Sydney Crago

Sydney L. Tyson, MD, MPH

Sydney M Crago

Szilárd Kiss, MD

T.Y. Alvin Liu, MD

Takashi Fujikado, MD, PhD

Tal Raviv, MD, FACS

Talia R. Kaden, MD

Talitha Dale

Tamer A. Macky, FRCSEd

Tania Tai, MD

Tania Tai, MD, is the vice chair of clinical operations and director of the glaucoma clinic and wet lab at the New York Eye and Ear Infirmary of Mount Sinai

Tanit Wongwibulsin, MD

Terri-Diann Pickering, MD

Glaucoma Center of San Francisco since 2001, member of Ophthalmology Times Editorial Board

Terry Kim, MD

Terry Lee, MD

Thales A.C. de Guimaraes, MD

Theodore Leng, MD, MS

Theorharis Theorharides, MD

Dr. Theorharides, professor of pharmacology and internal medicine and biochemistry, Tufts Unversity School of Medicine and New England Medical Center, Boston.

This program is initiated, funded, and developed by Biogen.

Thomas A. Albini, MD

Thomas Castillo, DO, MBA

Thomas Castillo is the owner of Vita Park Eye Associates in Beaver Dam, Wisconsin. He is a consultant for Lumenis.

Thomas M. Lietman, MD

Thomas P. Skernivitz

Authors

Trending on Eye Care Network - Ophthalmology Times

One day, three approvals: FDA expands options for ocular redness, thyroid eye disease, and presbyopia

Duravyu misses wet AMD end point again as EyePoint pivots to DME

The Retina TL;DR with Dr. Weng: Thriving in fellowship with Amer Alsoudi, MD, and Monia Reding, MD

Oculis completes randomization in PREDICT-1, the first genotype-guided registrational trial in dry eye disease

A vascular link: erectile dysfunction may signal glaucoma risk in men